Experimentally-validated model of glymphatic disruption due to spreading depolarization
Project Number1R21EB036217-01
Contact PI/Project LeaderTITHOF, JEFFREY
Awardee OrganizationUNIVERSITY OF MINNESOTA
Description
Abstract Text
Project Summary/Abstract
Spreading depolarization (SD) occurs following many acute neurological conditions and is characterized by the
loss of ion gradients across neuronal and astrocytic membranes. Recently, SD following stroke and cardiac arrest
has been linked to acute edema formation via excess influx of cerebrospinal fluid (CSF). This CSF is pulled into
the brain via the glymphatic system, which is a network of perivascular spaces (annular channels around vascu-
lature) connecting subarachnoid CSF with the brain interstitium. The mechanisms by which SD pulls CSF into
the brain are not well-understood. On the other hand, studies of migraine with aura indicate that SD can severely
diminish glymphatic function. To reconcile these seemingly contradictory results, we hypothesize that SD results
in three dominant competing effects that enhance or diminish glymphatic CSF flow: potassium ion-dependent
vasodilation/vasoconstriction, swelling of astrocyte endfeet, and osmotic pressure gradients in surrounding brain
tissue. To disentangle the significance of each effect experimentally, we propose the development of a novel
numerical simulation that couples a physiologically-realistic SD model to a detailed simulation of the glymphatic
system. We will do so by implementing and extending an existing physiologically-based model of SD to simulate
the spatiotemporal evolution of the concentration potassium, sodium, and chloride ions (Aim 1). We will then cou-
ple the SD model to an existing fluid network model to capture disruption to the glymphatic system (Aim 2). This
network model will implement the three SD-related competing effects described above. Finally, we will perform in
vivo experiments with transgenic mice using two-photon microscopy to quantify vasculature/PVSs, SD propaga-
tion, and alterations to CSF flow speed which will parameterize and validate our simulations. Development of this
validated simulation will constitute the first comprehensive model of SD-induced glymphatic disruption, offering
fundamental insights into competing mechanisms of enhanced/diminished glymphatic flow. In turn, this model
will lead to development of experimentally-testable hypotheses for mitigating SD-induced alteration to CSF flow
in a variety of neurological conditions.
Public Health Relevance Statement
Project Narrative
Spreading depolarization is a slow-moving wave of abnormal electrical activity in the brain that occurs in many
neurological conditions such as stroke. Recent experiments show that this phenomenon pulls cerebrospinal
fluid into the brain, killing additional brain cells, but the underlying mechanisms of this phenomenon are not
understood. We will use simulations and mouse experiments to uncover the relative importance of three different
likely mechanisms that lead to disruptions in the cerebrospinal fluid flow due to a spreading depolarization wave.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
555917996
UEI
KABJZBBJ4B54
Project Start Date
01-September-2024
Project End Date
31-August-2026
Budget Start Date
01-September-2024
Budget End Date
31-August-2026
Project Funding Information for 2024
Total Funding
$367,261
Direct Costs
$284,208
Indirect Costs
$83,053
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$367,261
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21EB036217-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21EB036217-01
Patents
No Patents information available for 1R21EB036217-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21EB036217-01
Clinical Studies
No Clinical Studies information available for 1R21EB036217-01
News and More
Related News Releases
No news release information available for 1R21EB036217-01
History
No Historical information available for 1R21EB036217-01
Similar Projects
No Similar Projects information available for 1R21EB036217-01